期刊文献+

替米沙坦采用不同给药时间用于高血压治疗的疗效分析 被引量:3

Observation on Efficacy of Telmisartan Administered at Different Times in Treatment of Hypertension
下载PDF
导出
摘要 目的探究在高血压治疗中替米沙坦不同给药时间的治疗效果。方法整群选取该院在2013年3月—2015年3月期间收治的96例高血压患者,根据给药时间的不同将其分为对照组及观察组,两组患者均采用替米沙坦进行治疗,对照组在早晨给药,而观察组在晚间给药,对两组患者的治疗效果。结果经治疗,两组的疗效对比差异无统计学意义(P>0.05),而杓型高血压比例对比,观察组明显高于对照组,差异有统计学意义(P<0.05)。结论高血压治疗中替米沙坦具有较好的治疗效果,尤其在晚间给药效果更佳,在临床上值得推广应用。 Objective To explore the clinical effect of telmisartan administered at different times in the treatment of hypertension. Methods 96 patients with hypertension admitted to our hospital from April 2013 and April 2015 were divided into control group and observation group according to different administration time. All the patients were treated with telmisartan. The control group underwent morning administration while the observation underwent evening administration. The therapeutic effect was compared between patients of the two groups. Results After treatment, no statistically significant difference can be found in therapeutic effect between the two groups, P>0.05, but in terms of the proportion of dipper hypertension, the observation group was significantly higher than the control group with statistical difference, P <0.05. Conclusion Telmisartan in the treatment of hypertension has good therapeutic effect especially when it is administrated in the evening,and this method should be widely applied in clinical practice.
出处 《中外医疗》 2015年第30期132-133,共2页 China & Foreign Medical Treatment
关键词 替米沙坦 给药时间 高血压 治疗效果 Telmisartan Administration time Hypertension Therapeutic effect
  • 相关文献

参考文献6

二级参考文献56

  • 1于海波,韩雅玲,王祖禄,张新娅,佟铭,许凤芝.替米沙坦降压疗效的临床研究[J].高血压杂志,2004,12(6):515-518. 被引量:21
  • 2陈洁霞,周江宁,刘荣玉.“杓型”与“非杓型”高血压患者的静息-活动和睡眠-觉醒昼夜节律[J].高血压杂志,2005,13(8):466-468. 被引量:20
  • 3孙宁玲,喜杨,荆珊,薛春光.左旋氨氯地平的时间药理学对纠正老年非杓型高血压的作用[J].中华高血压杂志,2007,15(1):26-29. 被引量:92
  • 4卫生部合理用药专家委员会.中国医师药师临床用药指南[M].重庆:重庆出版集团重庆出版社,2009:700-701.
  • 5Healey JS,Baranchuk A,Crystal E,et al.Prevention of atrial fibrillation with angiotensin converting enzyme inhibitors and angiotensin receptor blocders:a meta analysis[J].J Am Coll Cardiol,2005,45(11):832-1839.
  • 6Fuster V,Ryden LE,Cannom DS,et al.ACC/AHA/ESC 2006 guidelines for the management of patients with artrial fibrillation[J].Circulation,2006,114(7):700-752.
  • 7AFFIRM First Antiarrhythmic Drug Substudy Investigators.Maintenance of sinus rhythm in patient with atrial fibrillation:an AFFIRM substudy of the first antiarrhythmic drug l[J].J Am Coll Cardio,2003,42(1):20-29.
  • 8Li D,Shinagawa K,Pang L,et al.Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure[J].Circulation,2001,104(21):2608-2614.
  • 9Pedersen OD,Bagger H,Kober L,et al.Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction[J].Circulation,1999,100(4):376-380.
  • 10Madrid AH,Bueno MG,Rebollo JMG,et al.Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation:a prospective and randomized study[J].Circulation,2002,106(3):331-336.

共引文献131

同被引文献19

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部